Organ Preservation Solutions Market Size, Share, Trends, Growth Outlook

Organ Preservation Solutions Market is estimated to increase at a Compounded Annual Growth Rate of 6.1% CAGR over the forecast period from 2024 to 2030

The Organ Preservation Solutions Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (University of Wisconsin Solution (UW), Custodiol HTK, Perfadex, Hypothermosol, Others), By Application (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others), By Organ (Kidneys, Liver, Lungs, Heart, Others), By End-User (Organ Transplant Centers, Hospitals, Specialty Clinics).

An Introduction to Organ Preservation Solutions Market in 2024

In 2024, the market for organ preservation solutions continues to play a pivotal role in transplantation medicine, ensuring the viability and functionality of donated organs during storage and transportation before transplantation. Organ preservation solutions are specially formulated solutions containing a combination of electrolytes, antioxidants, osmotic agents, and nutrients that help maintain cellular homeostasis, prevent ischemic injury, and minimize organ damage during the preservation period. These solutions are used to flush, perfuse, and immerse donor organs, such as the heart, lungs, liver, kidneys, and pancreas, immediately after retrieval from deceased or living donors, preserving their viability and function until they can be transplanted into recipients. The market for organ preservation solutions encompasses a wide range of products tailored to specific organ types and preservation methods, including cold storage and machine perfusion techniques, with ongoing research aimed at optimizing solution compositions, enhancing preservation outcomes, and extending preservation times to improve organ utilization and transplant success rates. Technological advancements in organ preservation solutions include the development of hypothermic and normothermic perfusion systems, oxygenated perfusates, and additive solutions with cytoprotective agents and anti-inflammatory compounds to mitigate ischemia-reperfusion injury and improve graft quality. Moreover, the integration of biomarker monitoring, real-time imaging, and metabolic profiling enables assessment of organ viability and function during preservation, guiding clinical decision-making and improving transplant outcomes. With the growing demand for organ transplantation and the increasing complexity of donor-recipient matching, the market for organ preservation solutions continues to evolve, offering critical support for expanding access to life-saving organ transplants and improving patient outcomes in transplantation medicine.

Market Trend: Advancements in Hypothermic and Normothermic Organ Preservation Solutions

A prominent trend in the organ preservation solutions market is the continuous advancements in both hypothermic and normothermic organ preservation solutions. Hypothermic solutions have traditionally been used for organ preservation during transplantation, maintaining organs at low temperatures to slow metabolic processes and reduce cellular damage. However, there is a growing interest in normothermic solutions that maintain organs at near-physiological temperatures, allowing for continuous perfusion and metabolic activity ex vivo. This trend is driven by the desire to improve transplant outcomes by minimizing ischemic injury, preserving organ function, and extending preservation times compared to traditional cold storage methods. As researchers and pharmaceutical companies invest in developing novel formulations and technologies for both hypothermic and normothermic organ preservation, the market is witnessing significant innovation and growth, driven by the imperative to enhance organ quality and expand the donor pool for transplantation.

Market Driver: Increasing Demand for Organ Transplantation and Improved Outcomes

The primary driver propelling the organ preservation solutions market is the increasing demand for organ transplantation and the desire to improve transplant outcomes. With a growing prevalence of end-stage organ failure and a critical shortage of donor organs worldwide, there is a pressing need to optimize organ preservation methods to maximize organ utilization and improve transplant success rates. This driver is supported by demographic aging, lifestyle factors, and the rising burden of chronic diseases that contribute to the need for lifesaving organ transplantations. Additionally, advancements in surgical techniques, immunosuppressive therapies, and post-transplant care have led to improved patient survival and quality of life following transplantation, driving the demand for high-quality organ preservation solutions that ensure optimal organ function and viability. As transplant centers and healthcare systems prioritize improving patient outcomes and expanding access to transplantation, the demand for effective organ preservation solutions is expected to remain robust, driven by the imperative to address the critical unmet need for viable organs for transplantation.

Market Opportunity: Development of Customized and Specialty Organ Preservation Solutions

An opportunity within the organ preservation solutions market lies in the development of customized and specialty formulations tailored to specific organ types, transplantation procedures, and patient populations. Opportunities exist for pharmaceutical companies and biotechnology firms to innovate and differentiate their product offerings by developing organ-specific preservation solutions optimized for the unique physiological characteristics and preservation requirements of different organs, such as the heart, lungs, liver, kidneys, and pancreas. This opportunity is driven by the recognition of the diverse preservation needs and challenges associated with different organ types, including variations in metabolic activity, oxygen demand, perfusion requirements, and susceptibility to ischemic injury. Additionally, there is a growing demand for specialty preservation solutions tailored to specific patient populations, such as pediatric, geriatric, and high-risk patients, who may require personalized approaches to organ preservation to optimize transplant outcomes and minimize complications. Collaborations between pharmaceutical companies, transplant centers, and research institutions can facilitate the development and commercialization of customized and specialty organ preservation solutions, providing healthcare providers with innovative tools and strategies to enhance organ quality, expand the donor pool, and improve transplant outcomes for patients in need. As the field of organ preservation continues to evolve towards personalized and precision medicine approaches, the development of customized and specialty solutions presents opportunities for market differentiation, innovation, and growth in the organ preservation solutions market.

Organ Preservation Solutions Market Share Analysis: Normothermic Machine Perfusion Solutions

Among the various types of organ preservation solutions, the segment experiencing rapid growth in the organ preservation solutions market is Normothermic Machine Perfusion Solutions. Normothermic machine perfusion involves perfusing the donor organ with a solution at near-normal body temperature, which maintains the organ in a functioning state and allows for continuous assessment and optimization of its condition prior to transplantation. Normothermic machine perfusion solutions are designed to provide the necessary nutrients, oxygen, and protective agents to the organ while minimizing damage and preserving its viability. This method offers several advantages over traditional static cold storage and hypothermic machine perfusion, including improved organ function preservation, reduced ischemia-reperfusion injury, and increased opportunities for organ assessment and repair. With the growing emphasis on enhancing transplant outcomes and expanding the donor pool by utilizing marginal or extended criteria donor organs, normothermic machine perfusion solutions are gaining traction among organ transplant centers, hospitals, and specialty clinics. As healthcare providers increasingly adopt normothermic machine perfusion as a standard practice for organ preservation, the market for these solutions is expected to witness significant growth in the coming years.

Organ Preservation Solutions Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments across21ST Century Medicine, Accord Healthcare, Bridge to Life Ltd, Dr. Franz Koehler Chemie GmbH, Lifeline Scientific Inc, OrganOx Ltd, Paragonix Technologies Inc, Perfusion Solutions Inc, Shanghai Genext Pharmaceutical Technology, TransMedics, Waters Medical Systems LLC, XVIVO Perfusion

Organ Preservation Solutions Market Segmentation

By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Organ Preservation Solutions Market Companies

21ST Century Medicine
Accord Healthcare
Bridge to Life Ltd
Dr. Franz Koehler Chemie GmbH
Lifeline Scientific Inc
OrganOx Ltd
Paragonix Technologies Inc
Perfusion Solutions Inc
Shanghai Genext Pharmaceutical Technology
TransMedics
Waters Medical Systems LLC
XVIVO Perfusion

Reasons to Buy the Organ Preservation Solutions Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Organ Preservation Solutions Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Organ Preservation Solutions Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Organ Preservation Solutions Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Organ Preservation Solutions Market Size Outlook, $ Million, 2021 to 2030
3.2 Organ Preservation Solutions Market Outlook by Type, $ Million, 2021 to 2030
3.3 Organ Preservation Solutions Market Outlook by Product, $ Million, 2021 to 2030
3.4 Organ Preservation Solutions Market Outlook by Application, $ Million, 2021 to 2030
3.5 Organ Preservation Solutions Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Organ Preservation Solutions Industry
4.2 Key Market Trends in Organ Preservation Solutions Industry
4.3 Potential Opportunities in Organ Preservation Solutions Industry
4.4 Key Challenges in Organ Preservation Solutions Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Organ Preservation Solutions Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Organ Preservation Solutions Market Outlook by Segments
7.1 Organ Preservation Solutions Market Outlook by Segments, $ Million, 2021- 2030
By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics

8 North America Organ Preservation Solutions Market Analysis and Outlook To 2030
8.1 Introduction to North America Organ Preservation Solutions Markets in 2024
8.2 North America Organ Preservation Solutions Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Organ Preservation Solutions Market size Outlook by Segments, 2021-2030
By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics

9 Europe Organ Preservation Solutions Market Analysis and Outlook To 2030
9.1 Introduction to Europe Organ Preservation Solutions Markets in 2024
9.2 Europe Organ Preservation Solutions Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Organ Preservation Solutions Market Size Outlook by Segments, 2021-2030
By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics

10 Asia Pacific Organ Preservation Solutions Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Organ Preservation Solutions Markets in 2024
10.2 Asia Pacific Organ Preservation Solutions Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Organ Preservation Solutions Market size Outlook by Segments, 2021-2030
By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics

11 South America Organ Preservation Solutions Market Analysis and Outlook To 2030
11.1 Introduction to South America Organ Preservation Solutions Markets in 2024
11.2 South America Organ Preservation Solutions Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Organ Preservation Solutions Market size Outlook by Segments, 2021-2030
By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics
12 Middle East and Africa Organ Preservation Solutions Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Organ Preservation Solutions Markets in 2024
12.2 Middle East and Africa Organ Preservation Solutions Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Organ Preservation Solutions Market size Outlook by Segments, 2021-2030
By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
21ST Century Medicine
Accord Healthcare
Bridge to Life Ltd
Dr. Franz Koehler Chemie GmbH
Lifeline Scientific Inc
OrganOx Ltd
Paragonix Technologies Inc
Perfusion Solutions Inc
Shanghai Genext Pharmaceutical Technology
TransMedics
Waters Medical Systems LLC
XVIVO Perfusion

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
University of Wisconsin Solution (UW)
Custodiol HTK
Perfadex
Hypothermosol
Others
By Application
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Others
By Organ
Kidneys
Liver
Lungs
Heart
Others
By End-User
Organ Transplant Centers
Hospitals
Specialty Clinics
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)